Cardio Diagnostics Holdings (CDIO) Accounts Payables (2021 - 2025)
Historic Accounts Payables for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $150734.0.
- Cardio Diagnostics Holdings' Accounts Payables rose 10149.45% to $150734.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $150734.0, marking a year-over-year increase of 10149.45%. This contributed to the annual value of $87661.0 for FY2024, which is 6395.71% down from last year.
- As of Q3 2025, Cardio Diagnostics Holdings' Accounts Payables stood at $150734.0, which was up 10149.45% from $48724.0 recorded in Q2 2025.
- In the past 5 years, Cardio Diagnostics Holdings' Accounts Payables registered a high of $1.1 million during Q4 2022, and its lowest value of $33885.0 during Q4 2021.
- In the last 5 years, Cardio Diagnostics Holdings' Accounts Payables had a median value of $150734.0 in 2025 and averaged $318451.5.
- In the last 5 years, Cardio Diagnostics Holdings' Accounts Payables surged by 314254.98% in 2022 and then tumbled by 9200.49% in 2024.
- Over the past 5 years, Cardio Diagnostics Holdings' Accounts Payables (Quarter) stood at $33885.0 in 2021, then surged by 3142.55% to $1.1 million in 2022, then tumbled by 77.86% to $243213.0 in 2023, then plummeted by 63.96% to $87661.0 in 2024, then surged by 71.95% to $150734.0 in 2025.
- Its Accounts Payables stands at $150734.0 for Q3 2025, versus $48724.0 for Q2 2025 and $108181.0 for Q1 2025.